Daily Stock Analysis, ENZ, Enzo Biochem Inc, priceseries

Enzo Biochem Inc. Daily Stock Analysis
Stock Information
Open
3.36
Close
3.37
High
3.39
Low
3.17
Previous Close
3.32
Daily Price Gain
0.05
YTD High
4.46
YTD High Date
Jun 12, 2019
YTD Low
2.48
YTD Low Date
Mar 25, 2019
YTD Price Change
0.57
YTD Gain
20.36%
52 Week High
4.46
52 Week High Date
Jun 12, 2019
52 Week Low
2.32
52 Week Low Date
Dec 26, 2018
52 Week Price Change
-0.54
52 Week Gain
-13.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 17. 2017
7.51
Apr 4. 2017
8.20
12 Trading Days
9.25%
Link
LONG
Jun 13. 2017
10.21
Jun 30. 2017
11.09
13 Trading Days
8.66%
Link
LONG
Jan 15. 2019
3.26
Feb 12. 2019
3.79
19 Trading Days
16.16%
Link
LONG
Mar 29. 2019
2.73
Apr 25. 2019
3.53
18 Trading Days
29.12%
Link
LONG
Jun 3. 2019
3.28
Jun 20. 2019
3.96
13 Trading Days
20.80%
Link
Company Information
Stock Symbol
ENZ
Exchange
NYSE
Company URL
http://www.enzo.com
Company Phone
5167555500
CEO
Elazar Rabbani
Headquarters
New York
Business Address
60 EXECUTIVE BLVD, FARMINGDALE, NY 11735
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0000316253
About

Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

Description

Enzo Biochem, Inc., an integrated life science and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication levels, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 30 patient service centers in New York and New Jersey; and a free standing 'STAT' or rapid response laboratory in New York City, as well as a full-service phlebotomy department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment is involved in the research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.